Results 41 to 50 of about 35,394 (206)
Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma. [PDF]
Introduction Uterine sarcoma (US) is a rare tumor characterized by high aggressiveness, a tendency for recurrence and distant metastasis, and an extremely poor prognosis.
Yuan D +5 more
europepmc +2 more sources
Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report
Objective: Postirradiation sarcoma of the female genital tract is rare, but a recognized event. Most reported cases have been associated with history of radiotherapy for various gynecologic conditions, particularly cancer of the uterine cervix and ...
Korhan Kahraman +3 more
doaj +1 more source
BackgroundUterine sarcoma is a rare gynecologic tumor with a high degree of malignancy. There is a lack of effective prognostic tools to predict early death of uterine sarcoma.MethodsData on patients with uterine sarcoma registered between 2004 and 2015 ...
Zixuan Song +3 more
doaj +1 more source
Treatment of pure uterine sarcoma at the
AimThe aim of this retrospective study was to investigate the clinical and histopathological characteristics of the disease and treatment outcome of patients with pure uterine sarcomas.BackgroundUterine sarcomas are especially rare tumours, comprising ...
Guedea, Ferran; Radiation Oncology Department at the Institut Català d’Oncologia (ICO), Hospitalet de Belltvige, Barcelona, Spain +3 more
core +2 more sources
Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study
ABSTRACT Cancer care is often complicated by coagulopathy leading to thrombosis and bleeding. While venous thromboembolism (VTE) has been extensively studied, bleeding remains an underestimated threat. To address this knowledge gap, we leveraged the Epic Cosmos database to determine the impact of cancer‐associated clinically relevant bleeding (CRB) in ...
Ming Y. Lim +11 more
wiley +1 more source
Molecular tumor boards (MTB), interdisciplinary teams that use tumor genomic data to guide personalized treatment decisions, have emerged as a promising strategy in melanoma care, although their real‐world clinical impact remains uncertain. This retrospective study evaluated advanced melanoma patients to assess molecularly guided treatment ...
Glenn Geidel +26 more
wiley +1 more source
Radiotherapy in uterine sarcoma: a narrative review of international guidelines
Uterine sarcomas (US) are a rare heterogeneous disease and their management is controversial, probably due to lack of strong evidence. The aim of this review was to summarize the available international guidelines on radiotherapy (RT) of uterine sarcoma.
Cammelli, Silvia +7 more
core +1 more source
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley +8 more
wiley +1 more source
A rare diagnosis with a common presentation: a case report on uterine sarcoma
Uterine sarcomas are rare soft tissue tumors which constitute 3% to 7% of overall uterine malignancies. Endometrial stromal sarcoma (ESS) is a rare type of uterine sarcoma arising from the mesodermal component of the body of the uterus.
Gopalan, Ushadevi +3 more
core +1 more source
Membranous dysmenorrhea and decidual casts: A scoping review
Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley +1 more source

